Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs SREELEATHERS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS SREELEATHERS NOVARTIS/
SREELEATHERS
 
P/E (TTM) x 85.3 26.4 322.8% View Chart
P/BV x 2.7 1.4 192.1% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 NOVARTIS   SREELEATHERS
EQUITY SHARE DATA
    NOVARTIS
Mar-21
SREELEATHERS
Mar-21
NOVARTIS/
SREELEATHERS
5-Yr Chart
Click to enlarge
High Rs770170 453.2%   
Low Rs501110 455.5%   
Sales per share (Unadj.) Rs154.535.9 429.6%  
Earnings per share (Unadj.) Rs8.54.8 176.0%  
Cash flow per share (Unadj.) Rs13.45.3 250.7%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.2135.4 213.7%  
Shares outstanding (eoy) m24.6923.19 106.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.13.9 105.7%   
Avg P/E ratio x75.129.1 257.9%  
P/CF ratio (eoy) x47.526.2 181.1%  
Price / Book Value ratio x2.21.0 212.5%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,6913,246 483.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1,08532 3,344.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,814834 457.4%  
Other income Rs m3324 7,511.3%   
Total revenues Rs m4,146838 494.6%   
Gross profit Rs m267163 163.8%  
Depreciation Rs m12212 983.8%   
Interest Rs m773 2,213.3%   
Profit before tax Rs m400151 264.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m19140 479.5%   
Profit after tax Rs m209112 187.4%  
Gross profit margin %7.019.5 35.8%  
Effective tax rate %47.826.4 181.3%   
Net profit margin %5.513.4 41.0%  
BALANCE SHEET DATA
Current assets Rs m9,224184 5,010.6%   
Current liabilities Rs m3,57390 3,950.7%   
Net working cap to sales %148.211.2 1,319.2%  
Current ratio x2.62.0 126.8%  
Inventory Days Days176699 25.2%  
Debtors Days Days371,727,709 0.0%  
Net fixed assets Rs m2,4803,117 79.5%   
Share capital Rs m123232 53.2%   
"Free" reserves Rs m7,0182,907 241.4%   
Net worth Rs m7,1413,139 227.5%   
Long term debt Rs m00-   
Total assets Rs m11,7033,302 354.5%  
Interest coverage x6.244.6 13.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.30.3 129.0%   
Return on assets %2.43.5 70.1%  
Return on equity %2.93.6 82.4%  
Return on capital %6.74.9 135.4%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-692109 -634.8%  
From Investments Rs m952246 387.5%  
From Financial Activity Rs m-368-332 110.8%  
Net Cashflow Rs m-10922 -484.6%  

Share Holding

Indian Promoters % 0.0 72.3 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 5.3 15.4%  
FIIs % 0.0 5.0 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 27.7 105.8%  
Shareholders   45,141 7,724 584.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   HCL INFOSYS    MMTC    SUNDRAM FASTENERS    FUTURE CONSUMER    STC INDIA    



Today's Market

SGX Nifty Trades Flat, Hero MotoCorp's Investment in Ather Energy, UltraTech Cement Quarterly Results, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday. Benchmark indices ended with marginal gains in a choppy session supported by auto stocks.

Related Views on News

SREELEATHERS 2020-21 Annual Report Analysis (Annual Result Update)

Nov 18, 2021 | Updated on Nov 18, 2021

Here's an analysis of the annual report of SREELEATHERS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SREELEATHERS. Also includes updates on the valuation of SREELEATHERS.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jan 18, 2022 09:52 AM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS